Improve Physician Targeting

and rebalance Marketing Mix

PHARMACEUTICAL

OVERVIEW

The pharmaceutical industry is experiencing a complete transformation, with the increased usage of analytics solutions by traditional companies and new players to address issues, like the increasing costs associated to clinical investigation, regulatory compliance, and shifting market models.

These solutions are improving and accelerating the decision making process across all departments, speeding up the drug discovery process, enabling companies to create accurate predictive models to improve the drug pipeline and financial results.

What-if analysis and scenario modelling are crucial tools for managers of pharmaceutical companies to leverage sales and market data to improve corporate performance. In these financially challenged times, pharmaceutical executives have the obligation to create corporate goals, based on marketing strategies, to have a better understanding of the interaction between physicians, prescriptions, sales, and markets.

WHAT WE DO

At CXO, we design and develop dynamic solutions that provide actionable business intelligence and insight to support daily operations and strategic long-term decisions.

CXO creates solutions to help pharmaceutical companies monitor and rebalance their R&D portfolio, analyze performance by therapeutic classes across markets and healthcare providers, and optimize supply chain to fulfill the demand created by marketing activities and sales teams.

EXPERIENCE

Client Results

“CXO consulting services were key to understanding why our business was declining in one specific area. With the wealth of information provided by the reports they developed, we were able to define a turnaround strategy, based on accurate numbers.”